[On the pharmacology and toxicology of silymarin, an antihepatotoxic active principle from Silybum marianum (L.) Gaertn].
D000014:Abnormalities, Drug-Induced; D000577:Amides / Q000037:antagonists & inhibitors; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002251:Carbon Tetrachloride / Q000037:antagonists & inhibitors; D004285:Dogs; D004357:Drug Synergism; D004361:Drug Tolerance; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D005419:Flavonoids / Q000494:pharmacology* / Q000633:toxicity; D006027:Glycosides / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity; D006591:Hexobarbital / Q000494:pharmacology; D008099:Liver / Q000187:drug effects*; D008297:Male; D051379:Mice; D009183:Mycotoxins; D010936:Plant Extracts / Q000494:pharmacology; D011773:Pyruvates / Q000378:metabolism; D011817:Rabbits; D051381:Rats
D000577:Amides; D005419:Flavonoids; D006027:Glycosides; D009183:Mycotoxins; D010936:Plant Extracts; D011773:Pyruvates; D006591:Hexobarbital; D002251:Carbon Tetrachloride
Zur Pharmakologie und Toxikologie von Silymarin, des antihepatotoxischen Wirkprinzipes aus Silybum marianum (L.) Gaertn.